New research released on Wednesday suggests that Ozempic and similar medications may have unexpected side effects. Doctors in Massachusetts have found a link between the drug’s active ingredient semaglutide and a higher risk of a rare condition that can cause blindness called nonarteritic anterior ischemic optic…
The future of weight loss is fast approaching. At a recent scientific conference, drug companies showed off a variety of next-generation drugs for both obesity and type 2 diabetes. Some of these treatments might help people lose even more weight than current forerunners like Novo Nordisk’s semaglutide—the active…
It’s hard to go a day without hearing something new about the latest diabetes and obesity medications, semaglutide and tirzepatide. Usually, the buzz is positive, but there has been a persistent claim made about these drugs that would make any potential user wary: They don’t only help you lose weight—they supposedly…
Scientists in the U.K. seem to have unearthed yet another benefit of exercise: It could make our bodies better at using up certain kinds of fat. In a new study out this week, researchers found that endurance athletes were much better at burning off saturated fat compared to sedentary people with type 2 diabetes—a…
Results from the longest-running trial of semaglutide—the active ingredient in the popular drugs Ozempic and Wegovy—are in, and the verdict is decidedly positive. The study found that people taking semaglutide tended to maintain their initial weight loss for up to four years. Other trial data presented this week also…
At least 224 people have been injured after an iPhone app called t:connect drained the battery on its accompanying insulin pump, called t:slim X2, causing the pump to fail to deliver insulin. The FDA issued a Class I recall of the app on Wednesday, according to a press release, the most serious type of recall issued…
A constant feeling of strange tingling and numbness along a person’s legs might be much more common than assumed in some parts of the U.S., new research out Wednesday suggests. Researchers have found evidence that a substantial majority of older adults in Flint, Michigan are experiencing neuropathy, an uncomfortable…
The results of a nine-month investigation by health regulators in the European Union should be comforting for anyone taking Ozempic and other similar drugs to treat type 2 diabetes and/or obesity. EU officials said Friday that they failed to find evidence of a causative link between GLP-1 drugs and an increased risk…
The UK has embarked on a first-of-its-kind initiative that will make the lives of many diabetics much easier. The country is set to provide artificial pancreas devices to tens of thousands of people living with type 1 diabetes. The recently approved devices should eliminate the need for patients to constantly measure…
Getty Images
